Welcome to the PharmaFacts Resources PortalHere you will find the wide range of continually updated resources available from PharmaFacts highlighting guidance documents from a variety of regulatory agencies. Any requests for guidance documents can be send to This e-mail address is being protected from spambots. You need JavaScript enabled to view it |
|
Most Recent Guidances (All Agencies)
- FDA proposes draft guidelines intended to improve the representation of women in medical device clinical studies
- S2 R1
- Good Laboratory Practice for Nonclinical Laboratory Studies
- Codevelopment of Two or More Unmarketed Investigational Drugs for Use in Combination
- Investigational New Drug Applications (INDs)— Determining Whether Human Research Studies Can Be Conducted Without an IND
